EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Ablation Index‐Guided Radiofrequency Ablation for Atrial Fibrillation: An Updated Meta‐Analysis on Its Procedural Efficacy and Safety Profiles

Majd Al Deen Alhuarrat iD, David Flomenbaum, Marco Schiavone iD, Maisha Maliha iD, Mohamad Anas Oudih, Munther Hammad, Michael Freilich, Xiadong Zhang, Vincenzo Mirco La Fazia, Aung Lin, Jacopo Marazzato, Samuel J Apple und 10 weitere

Journal of Cardiovascular Electrophysiology · 2025-10 · 36 (10) · 2597-2607

DOI: 10.1111/jce.70039 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 11.08.2025. Verfasst von Majd Al Deen Alhuarrat und 21 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, University of Massachusetts Medical School, Worcester, Massachusetts, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atrial fibrillation (AF) is the most common sustained arrhythmia, with radiofrequency ablation (RFA) being a key treatment strategy. Despite its success, AF recurrence postablation is significant, and the ablation index (AI) was introduced to improve lesion quality and clinical outcomes. The aim of this study was to provide updated safety and efficacy data regarding AI‐guided ablation strategy. A systematic literature review was performed utilizing the PubMed, Embase, Cochrane, and Web‐of‐Science databases to retrieve double‐arm retrospective and prospective studies comparing AI‐guided ablation to non‐AI guided ablation from inception until January‐2024. The initial literature search yielded 700 studies, with 18 double‐arm full articles included in the analysis after screening and exclusions. The cohort consisted of 2030 patients undergoing AI‐guided ablation and 1580 undergoing non‐AI‐guided ablation. The average age of the cohort was 64.09 ± 9.86 years, with a median follow‐up period of 12 months. AI‐guided ablation was associated with lower AF recurrence (22% vs 32%, OR = 0.67, 95% CI = 0.59–0.77, p < 0.001). It also resulted in shorter total procedure time (145 min vs 159 min, SMD = ‐0.47, 95% CI = −0.78–‐0.16, p = 0.005) and fluoroscopy time (8.8 min vs 11.3 min, SMD = −0.35, 95% CI = ‐0.55 to ‐0.20, p < 0.001). No significant difference was observed in ablation time. First pass isolation was more likely with AI‐guided ablation (80% vs 60%, OR = 1.44, 95% CI = 1.04–2.01, p = 0.037). Complication rates were similar between groups (OR = 0.79, 95% CI = 0.47–1.32, p = 0.33). In conclusion, AI‐guided ablation significantly reduces AF recurrence and procedure times compared to non‐AI‐guided methods, without increasing complication rates, indicating its efficacy and safety in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCatheter AblationHumansTreatment OutcomeRecurrenceMiddle AgedMaleTime FactorsRisk FactorsFemaleAgedRisk AssessmentHeart RateAction PotentialsOperative Time

Stichwörter der Autor:innen

Meta‐analysisVisitagablation indexatrial fibrillationradiofrequency ablation

Autor:innen und Institutionen

  • Division of Cardiology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
  • Division of Internal Medicine, Montefiore Medical Center, Albert Einstein College Medicine, Bronx, New York, USA.
  • Department of Clinical Electrophysiology and Cardiac Pacing, Centro Cardiologico Monzino IRCCS, Milan, Italy.
  • Division of Internal Medicine, Jacobi Medical Center, Albert Einstein College Medicine, Bronx, New York, USA.
  • Division of Internal Medicine, Medstar Washington Center, Georgetown University School of Medicine, Washington, USA.
  • Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.

ORCID-Profile: Majd Al Deen Alhuarrat, Marco Schiavone, Maisha Maliha, Andrea Natale, Dhanunjaya Lakkireddy, Luigi Di Biase

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Alhuarrat, M. A. D., Flomenbaum, D., Schiavone, M., Maliha, M., Oudih, M. A., Hammad, M., Freilich, M., Zhang, X., La Fazia, V. M., Lin, A., Marazzato, J., Apple, S. J., Ammirati, G., Esagian, S., Al Zyoud, B., Zou, F., Minuti, A., Guttenplan, N., Mohanty, S., …, & Di Biase, L. (2025). Ablation Index‐Guided Radiofrequency Ablation for Atrial Fibrillation: An Updated Meta‐Analysis on Its Procedural Efficacy and Safety Profiles. Journal of Cardiovascular Electrophysiology, 36(10), 2597-2607. https://doi.org/10.1111/jce.70039

Vancouver

Alhuarrat MAD, Flomenbaum D, Schiavone M, Maliha M, Oudih MA, Hammad M, et al. Ablation Index‐Guided Radiofrequency Ablation for Atrial Fibrillation: An Updated Meta‐Analysis on Its Procedural Efficacy and Safety Profiles. Journal of Cardiovascular Electrophysiology. 2025;36(10):2597-2607. doi:10.1111/jce.70039

BibTeX
@article{Alhuarrat2025,
  author = {Alhuarrat, Majd Al Deen and Flomenbaum, David and Schiavone, Marco and Maliha, Maisha and Oudih, Mohamad Anas and Hammad, Munther and Freilich, Michael and Zhang, Xiadong and La Fazia, Vincenzo Mirco and Lin, Aung and Marazzato, Jacopo and Apple, Samuel J and Ammirati, Giuseppe and Esagian, Stepan and Al Zyoud, Batool and Zou, Fengwei and Minuti, Aurelia and Guttenplan, Nils and Mohanty, Sanghamitra and Natale, Andrea and Lakkireddy, Dhanunjaya and Di Biase, Luigi},
  title = {Ablation Index‐Guided Radiofrequency Ablation for Atrial Fibrillation: An Updated Meta‐Analysis on Its Procedural Efficacy and Safety Profiles},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2025},
  volume = {36},
  number = {10},
  pages = {2597--2607},
  doi = {10.1111/jce.70039}
}
Kostenlos starten →